BeOne Medicines (ONC) EBITDA Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 416.00 |
| Dec 31, 2025 | 80.00 |
| Sep 30, 2025 | 487.00 |
| Jun 30, 2025 | 569.00 |
| Mar 31, 2025 | 804.00 |
| Dec 31, 2024 | 496.00 |
| Sep 30, 2024 | -47.00 |
| Jun 30, 2024 | 2,324.00 |
| Mar 31, 2024 | 2,573.00 |
| Dec 31, 2023 | -4,335.00 |
| Sep 30, 2023 | 3,640.00 |
| Jun 30, 2023 | 2,936.00 |
| Mar 31, 2023 | 4,038.00 |
| Dec 31, 2022 | -1,020.00 |
| Sep 30, 2022 | 1,555.00 |
| Jun 30, 2022 | 1,593.00 |
| Mar 31, 2022 | -23,362.00 |
| Dec 31, 2021 | 31,301.00 |
| Sep 30, 2021 | 9,262.00 |
| Jun 30, 2021 | -32,816.00 |
| Mar 31, 2021 | 49,601.00 |
| Dec 31, 2020 | -119.00 |
| Sep 30, 2020 | 6,353.00 |
| Jun 30, 2020 | 17,117.00 |
| Mar 31, 2020 | -3,589.00 |
| Dec 31, 2019 | -5,928.00 |
| Sep 30, 2019 | -56,555.00 |
| Jun 30, 2019 | 16,602.00 |
| Mar 31, 2019 | 25,538.00 |
| Dec 31, 2018 | -19,985.00 |
| Sep 30, 2018 | 3,001.00 |
| Jun 30, 2018 | 3,171.00 |
| Mar 31, 2018 | 23,064.00 |
| Dec 31, 2017 | -62,331.00 |
| Jun 30, 2016 | -326,312.00 |
| Mar 31, 2016 | -243,959.00 |
| Dec 31, 2015 | 44,996.00 |
| Sep 30, 2015 | -53,819.00 |
| Jun 30, 2015 | 23,581.00 |